1,390
Views
79
CrossRef citations to date
0
Altmetric
Original Article

Botulinum toxin type A in post-stroke upper limb spasticity

, , , , , & show all
Pages 1983-1992 | Accepted 26 May 2010, Published online: 22 Jun 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Ilknur Aktas, Ezgi Kaya, Pinar Akpinar, Arzu Atici, Feyza Unlu Ozkan, Deniz Palamar & Kenan Akgun. (2020) Spasticity-induced Pectoralis minor syndrome: a case-report. Topics in Stroke Rehabilitation 27:4, pages 316-319.
Read now
Hitoshi Kagaya, Yoshihisa Masakado, Eiichi Saitoh, Toshiyuki Fujiwara, Masahiro Abo, Shin-ichi Izumi, Hiroyuki Nodera, Andrzej Dekundy, Reinhard Hiersemenzel, Christiane Martina Nalaskowski, Angelika Hanschmann & Ryuji Kaji. (2020) IncobotulinumtoxinA for upper- and lower-limb spasticity in Japanese patients. Current Medical Research and Opinion 36:5, pages 827-834.
Read now
Michelle Kaku & David M Simpson. (2016) Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity. Drug Design, Development and Therapy 10, pages 1085-1099.
Read now
Robert Teasell, Norine Foley, Shelialah Pereira, Keith Sequeira & Thomas Miller. (2012) Evidence to Practice: Botulinum Toxin in the Treatment of Spasticity Post Stroke. Topics in Stroke Rehabilitation 19:2, pages 115-121.
Read now
Wataru Kakuda, Masahiro Abo, Kazushige Kobayashi, Ryo Momosaki, Aki Yokoi, Akiko Fukuda, Hiroshi Ito, Ayumi Tominaga, Takuma Umemori & Yumi Kameda. (2011) Anti-spastic effect of low-frequency rTMS applied with occupational therapy in post-stroke patients with upper limb hemiparesis. Brain Injury 25:5, pages 496-502.
Read now

Articles from other publishers (73)

Alberto Esquenazi, Wolfgang H. Jost, Catherine C. Turkel, Theodore Wein & Rozalina Dimitrova. (2023) Treatment of adult spasticity with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine 102:S1, pages e32376.
Crossref
Katherine Cox, Merhawit Ghebrehiwet, Micah Kee, Brayden Rucker, Holly Flores, Ryan Ottwell & Matt Vassar. (2023) Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin. Clinical Drug Investigation 43:2, pages 85-95.
Crossref
Delaram Safarpour & Bahman Jabbari. 2023. Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment. Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment 539 555 .
Junekyung Lee, Min Ho Chun, Young Jin Ko, Shi-Uk Lee, Deog Young Kim & Nam-Jong Paik. (2022) Safety and efficacy of MT10107 in post-stroke upper limb spasticity treatment: A phase I randomized controlled trial. Medicine 101:44, pages e31367.
Crossref
Ryuji Kaji, Ai Miyashiro, Nori Sato, Taiki Furumoto, Toshiaki Takeuchi, Ryosuke Miyamoto, Tomoko Kohda, Yuishin Izumi & Shunji Kozaki. (2022) A Pilot Study of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Subtype A2 for Post-Stroke Lower Limb Spasticity: Comparison with OnabotulinumtoxinA. Toxins 14:11, pages 739.
Crossref
Etienne Ojardias, Edouard Ollier, Ludovic Lafaie, Thomas Celarier, Pascal Giraux & Laurent Bertoletti. (2022) Time course response after single injection of botulinum toxin to treat spasticity after stroke: Systematic review with pharmacodynamic model-based meta-analysis. Annals of Physical and Rehabilitation Medicine 65:3, pages 101579.
Crossref
Rozalina Dimitrova, Heakyung Kim, Jill Meilahn, Henry G. Chambers, Brad A. Racette, Marcin Bonikowski, Eun Sook Park, Emily McCusker, Chengcheng Liu & Mitchell F. Brin. (2022) Efficacy and safety of onabotulinumtoxinA with standardized physiotherapy for the treatment of pediatric lower limb spasticity: A randomized, placebo-controlled, phase III clinical trial. NeuroRehabilitation 50:1, pages 33-46.
Crossref
Po-Cheng Hsu, Ke-Vin Chang, Yi-Hsiang Chiu, Wei-Ting Wu & Levent Özçakar. (2022) Comparative Effectiveness of Botulinum Toxin Injections and Extracorporeal Shockwave Therapy for Post-Stroke Spasticity: A Systematic Review and Network Meta-Analysis. eClinicalMedicine 43, pages 101222.
Crossref
Rozalina Dimitrova, Emily McCusker, Mark Gormley, Darcy Fehlings, Katharine E. Alter, Susan Greaves, Chengcheng Liu & Mitchell F. Brin. (2021) Efficacy and safety of onabotulinumtoxinA with standardized occupational therapy for treatment of pediatric upper limb spasticity: Phase III placebo-controlled randomized trial. NeuroRehabilitation 49:3, pages 469-479.
Crossref
A. P. Kovalenko, I. A. Voznyuk & V. K. Misikov. (2021) Spasticity syndrome in cerebral pathology: evaluation and clinical models. Neurology, Neuropsychiatry, Psychosomatics 13:5, pages 68-75.
Crossref
S. E. Khatkova, V. P. Diagileva, L. V. Krylova, D. V. Pokhabov & A. G. Arutiunian. (2021) Effectiveness of early abobotulinum toxin (Dysport<sup>®</sup>) injections in patients with upper limb spastic paresis after traumatic brain injury in real clinical practice: results of a multicenter observational non-interventional prospective study (Adults with post Traumatic Brain Injury (TBI) upper limb (UL) spasticity – APTULS). Neurology, Neuropsychiatry, Psychosomatics 13:5, pages 48-55.
Crossref
Toru Takekawa, Mariko Ikegaya, Takafumi Etoh, Yasushi Shiio, Hiroshi Sugihara, Keiko Haraikawa, Nozomi Miyamoto & Masahiro Abo. (2021) Botulinum toxin treatment for difficult-to-treat finger pressure ulcers caused by severe hand flexion: case report. Journal of Wound Care 30:8, pages 653-659.
Crossref
Djamel Bensmail, Jörg Wissel, Isabelle Laffont, Olivier Simon, Astrid Scheschonka, Birgit Flatau-Baqué, Dirk Dressler & David M. Simpson. (2021) Efficacy of incobotulinumtoxinA for the treatment of adult lower-limb post-stroke spasticity, including pes equinovarus. Annals of Physical and Rehabilitation Medicine 64:2, pages 101376.
Crossref
Tsuyoshi Okuno, Toshiaki Takeuchi, Eiji Takeda, Yuisin Izumi & Ryuji Kaji. (2021) Clinical Uses of a Robot (Hybrid-Assisted Limb or HAL™) in Patients with Post-stroke Spasticity after Botulinum Toxin Injections. The Journal of Medical Investigation 68:3.4, pages 297-301.
Crossref
Klemens Fheodoroff, Tiina Rekand, Luisa Medeiros, Peter Koßmehl, Jörg Wissel, Djamel Bensmail, Astrid Scheschonka, Birgit Flatau-Baqué, Olivier Simon, Dirk Dressler & David M. Simpson. (2020) Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA. Health and Quality of Life Outcomes 18:1.
Crossref
Gerard E. Francisco, Wolfgang H. Jost, Ganesh Bavikatte, Daniel S. Bandari, Simon F.T. Tang, Michael C. Munin, Joan Largent, Aubrey M. Adams, Aleksej Zuzek & Alberto Esquenazi. (2020) Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician‐ and Patient‐Reported Satisfaction: Long‐Term Observational Results from the ASPIRE Study. PM&R 12:11, pages 1120-1133.
Crossref
Ziyad Ayyoub, Allison Brashear, Marta Banach, Robert Schoene, William Stringer, Terry Boodhoo, Irina Yushmanova, Rozalina Dimitrova & Mitchell F. Brin. (2020) Safety and Stability of Pulmonary Function in Patients with Decreased Respiratory Function Treated for Spasticity with OnabotulinumtoxinA. Toxins 12:10, pages 661.
Crossref
Gerard E. Francisco, Daniel S. Bandari, Ganesh Bavikatte, Wolfgang H. Jost, Emily McCusker, Joan Largent, Aleksej Zuzek & Alberto Esquenazi. (2020) High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study. Toxicon: X 7, pages 100040.
Crossref
Yoshihisa Masakado, Masahiro Abo, Kunitsugu Kondo, Satoru Saeki, Eiichi Saitoh, Andrzej Dekundy, Angelika Hanschmann & Ryuji Kaji. (2020) Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE). Journal of Neurology 267:7, pages 2029-2041.
Crossref
Shiyu Jia, Yang Liu, Liuyan Shen, Xue Liang, Xiaomin Xu & Youdong Wei. (2020) Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials. Journal of Stroke and Cerebrovascular Diseases 29:6, pages 104682.
Crossref
Christina Marciniak, Michael C. Munin, Allison Brashear, Bruce S. Rubin, Atul T. Patel, Jaroslaw Slawek, Angelika Hanschmann, Reinhard Hiersemenzel & Elie P. Elovic. (2020) IncobotulinumtoxinA Treatment in Upper‐Limb Poststroke Spasticity in the Open‐Label Extension Period of PURE: Efficacy in Passive Function, Caregiver Burden, and Quality of Life. PM&R 12:5, pages 491-499.
Crossref
Maria Ilenia De Bartolo, Nicoletta Manzo, Gina Ferrazzano, Viola Baione, Daniele Belvisi, Giovanni Fabbrini, Alfredo Berardelli & Antonella Conte. (2020) Botulinum Toxin Effects on Sensorimotor Integration in Focal Dystonias. Toxins 12:5, pages 277.
Crossref
Masahiro Abo, Takashi Shigematsu, Hiroyoshi Hara, Yasuko Matsuda, Akinori Nimura, Yoshiyuki Yamashita & Kaoru Takahashi. (2020) Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase. Toxins 12:2, pages 127.
Crossref
Takanori Ro, Tetsuo Ota, Tsukasa Saito & Ou Oikawa. (2020) Spasticity and Range of Motion Over Time in Stroke Patients Who Received Multiple-Dose Botulinum Toxin Therapy. Journal of Stroke and Cerebrovascular Diseases 29:1, pages 104481.
Crossref
Dhanya Vijayakumar & Joseph Jankovic. 2020. Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine. Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine 43 112 .
Takatoshi Hara, Ryo Momosaki, Masachika Niimi, Naoki Yamada, Hiroyoshi Hara & Masahiro Abo. (2019) Botulinum Toxin Therapy Combined with Rehabilitation for Stroke: A Systematic Review of Effect on Motor Function. Toxins 11:12, pages 707.
Crossref
Yuichi Hirakawa, Soichiro Koyama, Shigeo Tanabe, Kazuya Takeda, Tetsuya Ueda, Ikuo Motoya, Hiroaki Sakurai, Yoshikiyo Kanada, Nobutoshi Kawamura, Mami Kawamura, Junji Nagata & Tetsuo Kanno. (2019) Combined effects of botulinum toxin type A and repetitive transcranial magnetic stimulation with intensive motor training immediately after injection in a patient with chronic stroke: A case report. Journal of Hand Therapy 32:4, pages 519-524.
Crossref
Aukje Andringa, Ingrid van de Port, Erwin van Wegen, Johannes Ket, Carel Meskers & Gert Kwakkel. (2019) Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis. Archives of Physical Medicine and Rehabilitation 100:9, pages 1703-1725.
Crossref
Philippe Marque, Angelique Denis, David Gasq, Emmanuelle Chaleat-Valayer, Alain Yelnik, Cyrille Colin & Dominic Pérennou. (2019) Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin. Annals of Physical and Rehabilitation Medicine 62:4, pages 207-213.
Crossref
Li-Chun Sun, Rong Chen, Chuan Fu, Ying Chen, Qianli Wu, RuiPeng Chen, XueJuan Lin & Sha Luo. (2019) Efficacy and Safety of Botulinum Toxin Type A for Limb Spasticity after Stroke: A Meta-Analysis of Randomized Controlled Trials. BioMed Research International 2019, pages 1-17.
Crossref
Raikan Buyukavci, Semra Akturk & Yüksel Ersoy. (2018) Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study. European Journal of Physical and Rehabilitation Medicine 54:5.
Crossref
Elina Zakin & David Simpson. (2018) Evidence on botulinum toxin in selected disorders. Toxicon 147, pages 134-140.
Crossref
A. P. Kovalenko & V. K. Misikov. (2018) Botulinum toxin in treatment of lower limb spasticity in patients with brain damage. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:9, pages 28.
Crossref
Iman Moeini-Naghani & Bahman Jabbari. 2018. Botulinum Toxin Treatment in Clinical Medicine. Botulinum Toxin Treatment in Clinical Medicine 213 230 .
Tie Li, Xu-Yun Hua, Mou-Xiong Zheng, Yu-Lan Zhu, Yan-Qun Qiu, Yun-Dong Shen, Jian-Guang Xu, Yu-Dong Gu & Wen-Dong Xu. (2017) Electrophysiological evidence for pre-attention information processing improvement in patients with central hemiplegic after peripheral nerve rewiring: a pilot study. Scientific Reports 7:1.
Crossref
Alastair Carruthers & Jean Carruthers. 2017. Botulinum Toxins. Botulinum Toxins 1 12 .
Deog Young KimYun-Hee KimJongmin LeeWon Hyuk ChangMin-Wook KimSung-Bom PyunWoo-Kyoung YooSuk Hoon OhnKi Deok ParkByung-Mo OhSeong Hoon LimKang Jae JungByung-Ju RyuSun ImSung Ju JeeHan Gil SeoUeon Woo RahJoo Hyun ParkMin Kyun SohnMin Ho ChunHee Suk ShinSeong Jae LeeYang-Soo LeeSi-Woon ParkYoon Ghil ParkNam Jong PaikSam-Gyu LeeJu Kang LeeSeong-Eun KohDon-Kyu KimGeun-Young ParkYong Il ShinMyoung-Hwan KoYong Wook KimSeung Don YooEun Joo KimMin-Kyun OhJae Hyeok ChangSe Hee JungTae-Woo KimWon-Seok KimDae Hyun KimTai Hwan ParkKwan-Sung LeeByong-Yong HwangYoung Jin Song. (2017) Clinical Practice Guideline for Stroke Rehabilitation in Korea 2016. Brain & Neurorehabilitation 10:Suppl 1.
Crossref
Raymond L. Rosales, Fran Efendy, Ericka SA Teleg, Mary MD Delos Santos, Mary CE Rosales, Marc Ostrea, Michelle J Tanglao & Arlene R. Ng. (2016) Botulinum toxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysis. Journal of the Neurological Sciences 371, pages 6-14.
Crossref
Samar M. Hatem, Geoffroy Saussez, Margaux della Faille, Vincent Prist, Xue Zhang, Delphine Dispa & Yannick Bleyenheuft. (2016) Rehabilitation of Motor Function after Stroke: A Multiple Systematic Review Focused on Techniques to Stimulate Upper Extremity Recovery. Frontiers in Human Neuroscience 10.
Crossref
David M. SimpsonMark HallettEric J. AshmanCynthia L. ComellaMark W. GreenGary S. GronsethMelissa J. ArmstrongDavid GlossSonja PotrebicJoseph JankovicBarbara P. KarpMarkus NaumannYuen T. SoStuart A. Yablon. (2016) Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Neurology 86:19, pages 1818-1826.
Crossref
Michael Ka-Wing See, Benedict Beng-Teck Taw, Edward Man-Tai Chan, Linda Yuk-Ying Chan, Shuk-Man Lo, Terrence Wing-Cheung Kwong, Gilberto Ka-Kit Leung & Wai-Man Lui. (2016) Botulinum toxin injection and rehabilitation for neurosurgical patients with spasticity. Surgical Practice 20:2, pages 66-72.
Crossref
Chetan P. Phadke, Chitra K. Balasubramanian, Alanna Holz, Caitlin Davidson, Farooq Ismail & Chris Boulias. (2015) Adverse Clinical Effects of Botulinum Toxin Intramuscular Injections for Spasticity. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 43:2, pages 298-310.
Crossref
Elie Paul Elovic, Michael C. Munin, Petr Kaňovský, Angelika Hanschmann, Reinhard Hiersemenzel & Christina Marciniak. (2015) Randomized, placebo‐controlled trial of incobotulinumtoxina for upper‐limb post‐stroke spasticity. Muscle & Nerve 53:3, pages 415-421.
Crossref
Jennifer A Baker & Gavin Pereira. (2014) The efficacy of Botulinum Toxin A on improving ease of care in the upper and lower limbs: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach. Clinical Rehabilitation 29:8, pages 731-740.
Crossref
Xu-Yun Hua, Yan-Qun Qiu, Tie Li, Mou-Xiong Zheng, Yun-Dong Shen, Su Jiang, Jian-Guang Xu, Yu-Dong Gu & Wen-Dong Xu. (2015) Contralateral Peripheral Neurotization for Hemiplegic Upper Extremity After Central Neurologic Injury. Neurosurgery 76:2, pages 187-195.
Crossref
Yoshihiko Horimoto, Aki Inagaki, Mika Yoshikawa, Kumi Kanbe, Hajime Tanaka, Reika Ando, Hiroaki Hibino, Toshihisa Tajima, Kazutoshi Fukagawa & Hidehiro Kabasawa. (2015) Therapeutic outcome of onabotulinum toxin type A in patients with upper limb spasticity. Rinsho Shinkeigaku 55:8, pages 544-549.
Crossref
Dr. Jodie Copley & Dr. Kathy Kuipers. 2014. Neurorehabilitation of the Upper Limb Across the Lifespan. Neurorehabilitation of the Upper Limb Across the Lifespan 321 338 .
Loree K. Kalliainen & Virginia H. O'Brien. (2014) Current uses of botulinum toxin A as an adjunct to hand therapy interventions of hand conditions. Journal of Hand Therapy 27:2, pages 85-95.
Crossref
E Alexandra Brown, Sonja G Schütz & David M Simpson. (2014) Botulinum toxin for neuropathic pain and spasticity: an overview. Pain Management 4:2, pages 129-151.
Crossref
Nathaniel H. Mayer, Richard L. Harvey & Thomas K. Watanabe. (2014) Use of a Resting Hand Orthosis for the Hemiparetic Hand After Stroke. PM&R 6:2, pages 188-195.
Crossref
Mayank S. Pathak & Allison Brashear. 2014. Manual of Botulinum Toxin Therapy. Manual of Botulinum Toxin Therapy 107 118 .
Toru TAKEKAWA, Takatoshi HARA, Wataru KAKUDA, Kazushige KOBAYASHI, Yousuke SASE & Masahiro ABO. (2014) Clinical Efficacy of a Double Injection Protocol of Botulinum Toxin Type A for Upper Limb Hemiparesis after Stroke. The Japanese Journal of Rehabilitation Medicine 51:1, pages 38-46.
Crossref
Naoki Yamada, Wataru Kakuda, Takahiro Kondo, Sugao Mitani, Masato Shimizu & Masahiro Abo. (2014) Local Muscle Injection of Botulinum Toxin Type A Synergistically Improves the Beneficial Effects of Repetitive Transcranial Magnetic Stimulation and Intensive Occupational Therapy in Post-Stroke Patients with Spastic Upper Limb Hemiparesis. European Neurology 72:5-6, pages 290-298.
Crossref
Luba Nalysnyk, Spyridon Papapetropoulos, Philip Rotella, Jason C Simeone, Katharine E Alter & Alberto Esquenazi. (2013) OnabotulinumtoxinA muscle injection patterns in adult spasticity: a systematic literature review. BMC Neurology 13:1.
Crossref
Jennifer A Baker & Gavin Pereira. (2013) The efficacy of Botulinum Toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach. Clinical Rehabilitation 27:12, pages 1084-1096.
Crossref
Toru Takekawa, Masahiro Abo, Kazuaki Ebihara, Kensuke Taguchi, Yousuke Sase & Wataru Kakuda. (2013) Long-term effects of injection of botulinum toxin type A combined with home-based functional training for post-stroke patients with spastic upper limb hemiparesis. Acta Neurologica Belgica 113:4, pages 469-475.
Crossref
Stephen Ashford & Lynne Turner‐Stokes. (2013) Systematic Review of Upper‐limb Function Measurement Methods in Botulinum Toxin Intervention for Focal Spasticity. Physiotherapy Research International 18:3, pages 178-189.
Crossref
Pedro J. Garcia-Ruiz. (2013) Aplicaciones de la toxina botul?nica en Neurolog?a. Medicina Cl?nica 141:1, pages 33-36.
Crossref
Alberto Esquenazi, Alberto Albanese, Michael B. Chancellor, Elie Elovic, Karen R. Segal, David M. Simpson, Christopher P. Smith & Anthony B. Ward. (2013) Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome. Toxicon 67, pages 115-128.
Crossref
Norine Foley, Shelialah Pereira, Katherine Salter, Manuel Murie Fernandez, Mark Speechley, Keith Sequeira, Thomas Miller & Robert Teasell. (2013) Treatment With Botulinum Toxin Improves Upper-Extremity Function Post Stroke: A Systematic Review and Meta-Analysis. Archives of Physical Medicine and Rehabilitation 94:5, pages 977-989.
Crossref
Ryuji Kaji. (2013) Direct central action of intramuscularly injected botulinum toxin: is it harmful or beneficial?. The Journal of Physiology 591:4, pages 749-749.
Crossref
Richard D. ZorowitzPatrick J. GillardMichael Brainin. (2013) Poststroke spasticity. Neurology 80:3_supplement_2.
Crossref
Katharina S. SunnerhagenJohn OlverGerard E. Francisco. (2013) Assessing and treating functional impairment in poststroke spasticity. Neurology 80:3_supplement_2.
Crossref
Gerard E. FranciscoJohn R. McGuire. (2012) Poststroke Spasticity Management. Stroke 43:11, pages 3132-3136.
Crossref
Raymond L. Rosales, Keng He Kong, Khean Jin Goh, Witsanu Kumthornthip, Vincent Chung Tong Mok, Mary Mildred Delgado-De Los Santos, Karen Sui Geok Chua, Saini Jeffery bin Freddy Abdullah, Benjamin Zakine, Pascal Maisonobe, Axel Magis & K. S. Lawrence Wong. (2012) Botulinum Toxin Injection for Hypertonicity of the Upper Extremity Within 12 Weeks After Stroke. Neurorehabilitation and Neural Repair 26:7, pages 812-821.
Crossref
Anila M. Thomas & David M. Simpson. (2012) Contralateral weakness following botulinum toxin for poststroke spasticity. Muscle & Nerve 46:3, pages 443-448.
Crossref
Domenico Intiso. (2012) Therapeutic Use of Botulinum Toxin in Neurorehabilitation. Journal of Toxicology 2012, pages 1-12.
Crossref
Ryuji Kaji. (2011) New and emerging indications of botulinum toxin therapy. Parkinsonism & Related Disorders 17, pages S25-S27.
Crossref
Pierre Burbaud, Camille Ducerf, Emmanuelle Cugy, Jean-Louis Dubos, François Muller, Dominique Guehl, Patrick Dehail, Didier Cugy, Nicholas Moore, Alain Lagueny & Pierre-Alain Joseph. (2011) Botulinum toxin treatment in neurological practice: how much does it really cost? A prospective cost-effectiveness study. Journal of Neurology 258:9, pages 1670-1675.
Crossref
E. Duarte, E. Marco, C. Cervantes, D. D?az, S.C. Chiarella & F. Escalada. (2011) Efectos de la toxina botul?nica tipo A y electroestimulaci?n en la espasticidad flexora distal de la extremidad superior en el ictus. Ensayo cl?nico aleatorizado. Rehabilitaci?n 45:3, pages 194-201.
Crossref
Dennis A. NowakF. Binkofski, M. Dafotakis, C. Dohle, C. Eickhof, D. Ertelt, C. Grefkes, F. Hamzei, B. Hauptmann, S. Hesse, R. Horst, H. Hummelsheim, J. Liepert, D.A. Nowak, C. Müller, T. Platz, C.I.E. Renner, V. Urquizo, M.S. Vry, C. Werner & H. Woldag. 2011. Handfunktionsstörungen in der Neurologie. Handfunktionsstörungen in der Neurologie 191 301 .
Eleanor L. Olvey, Edward P. Armstrong & Amy J. Grizzle. (2010) Contemporary Pharmacologic Treatments for Spasticity of the Upper Limb After Stroke: A Systematic Review. Clinical Therapeutics 32:14, pages 2282-2303.
Crossref
Akio KIMURA, Masahiro ABO, Nobuyuki KAWATE, Yuka OSAKO, Kazuaki SUYAMA, Toshio MAEDA, Yasuyuki UECHI & Masaru IWASAKI. (2010) Efficacy and Safety of Botulinum Toxin Type A in treating Upper Limb Spasticity in Post-stroke Patients : A Multicenter, Double-blind, Placebo-controlled Trial followed by an Open-label Trial. The Japanese Journal of Rehabilitation Medicine 47:10, pages 714-727.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.